NAMA
Nikko Asset Management Americas’s Teladoc Health TDOC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,136,936
| Closed | -$40.5M | – | 192 |
|
|
2024
Q2 | $40.5M | Sell |
4,136,936
-3,044,752
| -42% | -$29.8M | 0.47% | 46 |
|
|
2024
Q1 | $108M | Sell |
7,181,688
-283,186
| -4% | -$4.28M | 1.08% | 26 |
|
|
2023
Q4 | $161M | Sell |
7,464,874
-222,772
| -3% | -$4.8M | 1.55% | 15 |
|
|
2023
Q3 | $143M | Sell |
7,687,646
-166,836
| -2% | -$3.1M | 1.71% | 18 |
|
|
2023
Q2 | $199M | Sell |
7,854,482
-179,306
| -2% | -$4.54M | 2.09% | 14 |
|
|
2023
Q1 | $206M | Sell |
8,033,788
-91,443
| -1% | -$2.34M | 2.37% | 15 |
|
|
2022
Q4 | $192M | Sell |
8,125,231
-70,088
| -0.9% | -$1.66M | 2.77% | 10 |
|
|
2022
Q3 | $210M | Sell |
8,195,319
-91,609
| -1% | -$2.35M | 2.68% | 12 |
|
|
2022
Q2 | $272M | Sell |
8,286,928
-163,361
| -2% | -$5.37M | 3.36% | 10 |
|
|
2022
Q1 | $611M | Sell |
8,450,289
-304,769
| -3% | -$22M | 4.49% | 5 |
|
|
2021
Q4 | $810M | Buy |
8,755,058
+1,349,776
| +18% | +$125M | 4.26% | 6 |
|
|
2021
Q3 | $933M | Buy |
7,405,282
+1,714,753
| +30% | +$216M | 4.01% | 4 |
|
|
2021
Q2 | $946M | Buy |
5,690,529
+1,244,967
| +28% | +$207M | 3.71% | 6 |
|
|
2021
Q1 | $808M | Buy |
4,445,562
+1,621,495
| +57% | +$295M | 3.96% | 3 |
|
|
2020
Q4 | $565M | Buy |
2,824,067
+1,791,008
| +173% | +$358M | 3.21% | 5 |
|
|
2020
Q3 | $229M | Buy |
1,033,059
+933,432
| +937% | +$207M | 2.03% | 12 |
|
|
2020
Q2 | $19M | Sell |
99,627
-107,482
| -52% | -$20.5M | 0.25% | 63 |
|
|
2020
Q1 | $32.1M | Sell |
207,109
-711,246
| -77% | -$110M | 0.6% | 43 |
|
|
2019
Q4 | $76.9M | Sell |
918,355
-122,972
| -12% | -$10.3M | 1.21% | 25 |
|
|
2019
Q3 | $70.5M | Buy |
1,041,327
+319,556
| +44% | +$21.6M | 1.25% | 22 |
|
|
2019
Q2 | $47.9M | Buy |
721,771
+551,755
| +325% | +$36.6M | 0.94% | 33 |
|
|
2019
Q1 | $9.45M | Buy |
170,016
+169,502
| +32,977% | +$9.42M | 0.25% | 67 |
|
|
2018
Q4 | $25K | Buy |
+514
| New | +$25K | ﹤0.01% | 139 |
|